153 related articles for article (PubMed ID: 9853281)
1. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Technical note.
Gaspari F; Perico N; Signorini O; Caruso R; Remuzzi G
Kidney Int; 1998 Dec; 54(6):2146-50. PubMed ID: 9853281
[TBL] [Abstract][Full Text] [Related]
2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
Schädeli F; Marti HP; Frey FJ; Uehlinger DE
Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
[TBL] [Abstract][Full Text] [Related]
4. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
Wang CH; Ko WJ; Chou NK; Wang SS
Transplant Proc; 2004 Oct; 36(8):2390-2. PubMed ID: 15561259
[TBL] [Abstract][Full Text] [Related]
5. A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation.
Meier-Kriesche HU; Kaplan B; Brannan P; Kahan BD; Portman RJ
Ther Drug Monit; 1998 Aug; 20(4):401-7. PubMed ID: 9712465
[TBL] [Abstract][Full Text] [Related]
6. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
[TBL] [Abstract][Full Text] [Related]
7. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.
Primmett DR; Levine M; Kovarik JM; Mueller EA; Keown PA
Ther Drug Monit; 1998 Jun; 20(3):276-83. PubMed ID: 9631924
[TBL] [Abstract][Full Text] [Related]
9. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
10. Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration.
Gaspari F; Anedda MF; Signorini O; Remuzzi G; Perico N
J Am Soc Nephrol; 1997 Apr; 8(4):647-52. PubMed ID: 10495795
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cyclosporine absorption profiles over a 12-month period in stable pediatric renal transplant recipients.
Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R
Transplant Proc; 2003 Jun; 35(4):1300-3. PubMed ID: 12826143
[TBL] [Abstract][Full Text] [Related]
13. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants.
John U; Ullrich S; Roskos M; Misselwitz J
Transplant Proc; 2005 Apr; 37(3):1608-11. PubMed ID: 15866686
[TBL] [Abstract][Full Text] [Related]
14. Validation of sparse sampling strategies to estimate cyclosporine A area under the concentration-time curve using either a specific radioimmunoassay or high-performance liquid chromatography method.
Koristkova B; Grundmann M; Brozmanova H; Perinova I; Safarcik K
Ther Drug Monit; 2010 Oct; 32(5):586-93. PubMed ID: 20683391
[TBL] [Abstract][Full Text] [Related]
15. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
Bunnag S; Vareesangthip K; Ong-ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of limited sampling strategies for estimation of cyclosporine area under the concentration-time curve in hematopoietic stem cell transplant patients.
Hadjibabaie M; Vazirian I; Iravani M; Moosavi SA; Alimoghaddam K; Ghavamzadeh A; Rezaee S
Ther Drug Monit; 2011 Dec; 33(6):673-80. PubMed ID: 22011723
[TBL] [Abstract][Full Text] [Related]
17. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
18. A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients.
Balram C; Sivathasan C; Cheung YB; Tan SB; Tan YS
J Heart Lung Transplant; 2002 Sep; 21(9):1016-21. PubMed ID: 12231373
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
20. Neoral monitoring by limited sampling area under the concentration time curve in stable indian renal transplant recipients.
Jaiswal J; Gupta SK; Dash SC; Tiwari SC; Mehta SN; Gupta YK; Velpandian T
Transplant Proc; 2003 Jun; 35(4):1298-9. PubMed ID: 12826142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]